Swedish Orphan Biovitrum AB (publ) banner

Intrinsic Value

The intrinsic value of Swedish Orphan Biovitrum AB (publ) (SOBI) under the Base Case is SEK per share. Compared with the current market price of 464 SEK, the stock appears .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

SOBI Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when SOBI is below its intrinsic value
Today Hidden ·
SOBI Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to SOBI

Fundamental Analysis

What Swedish Orphan Biovitrum AB Does

Biotechnology Health Care

Swedish Orphan Biovitrum, usually called Sobi, is a biopharmaceutical company that develops and sells medicines for rare diseases. Its main focus is on blood disorders, immune-related conditions, and other specialist therapies that treat patients with serious illnesses that are often hard to manage with standard drugs.

Headquarters
Sweden SE
Employees
1 969
IPO date
Sep 15, 2006
Read the full company overview
View Company Overview

Swedish Orphan Biovitrum has a narrow economic moat

No Moat Narrow Wide

Patents and temporary market protections on some of Sobi’s rare-disease medicines delay direct copies, helping it retain sales while rivals develop and test alternatives. Other medicines can still treat the same conditions, so these protections provide a limited barrier rather than keeping all competitors out.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · October 27, 2026

Strong portfolio growth led Sobi to raise its full-year revenue outlook, while management kept its adjusted EBITDA margin outlook unchanged.

Open the earnings call
EPS
kr6.89
Expected
kr6.22
Surprise
+10.8%
Stock, day of the call
+1.1%
View Earnings Call

Past 12 months

Continue SOBI Research

Decided on Swedish Orphan Biovitrum? Get an email when SOBI reaches the price you’d buy at. Free with an account.

Other Swedish Orphan Biovitrum listings

What is the Intrinsic Value of one SOBI stock?

The intrinsic value for Swedish Orphan Biovitrum AB (publ) (SOBI) under the Base Case is SEK.

Is SOBI stock undervalued or overvalued?

Compared with the current market price of 464 SEK, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top